Skeletal muscle abnormalities and outcomes after liver transplantation
Aldo J. Montano‐Loza – 11 September 2014
Adverse cardiac events after orthotopic liver transplantation: A cross‐sectional study in 389 consecutive patients
Ramona Nicolau‐Raducu, Marina Gitman, Donald Ganier, George E. Loss, Ari J. Cohen, Hamang Patel, Nigel Girgrah, Krish Sekar, Bobby Nossaman – 11 September 2014 – Current American College of Cardiology/American Heart Association guidelines caution that preoperative noninvasive cardiac tests may have poor predictive value for detecting coronary artery disease in liver transplant candidates.
What is the future of pediatric liver transplantation? Optimal management of long‐term recipients
Robert S. Venick – 11 September 2014
Waiting time and transplantation for hepatocellular cancer: A balance between tempus fugit and carpe diem
Quirino Lai, Jan Lerut, For the European Hepatocellular Cancer Liver Transplant (EurHeCaLT) Study Group – 11 September 2014
Reply
Cynthia Guy, Ayako Suzuki, Manal Abdelmalek, James Burchette, Anna Mae Diehl – 11 September 2014
Reply
Karim J. Halazun, Abbas A. Rana, Rachel E. Patzer, Benjamin Samstein, Robert S. Brown, Jean C. Emond – 11 September 2014
Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation
Natalie E. Nierenberg, Debra D. Poutsiaka, Jennifer K. Chow, Jeffrey Cooper, Lori Lyn Price, Richard B. Freeman, Richard Rohrer, David R. Snydman – 10 September 2014 – Infection after liver transplantation (LT) remains a leading cause of morbidity and mortality. The risk of infection after LT is highest in those who are most immunosuppressed, but to date, no standard blood marker of one's degree of immunosuppression or risk index has been established.
Hepatology highlights
Jean‐François Dufour – 10 September 2014
Reply
Chien‐Hsieh Chiang, Kuo‐Chin Huang – 10 September 2014
Hepatology highlights
Jean‐François Dufour – 10 September 2014